Treatment with HSP significantly upregulated hypothalamic KISS-1 and GnRH and hypophyseal GnRHr, but not KISS-1r, in comparison to that in the CP-treated group, as shown in Figure 5A–D. The gene discussed is GNRHR; the disease is hereditary spastic paraplegia.